Clinical Trials Browser

Phase 2 × Carcinoma, Transitional Cell × tesetaxel × Clear all

NCT01215877 2012-07-11

Tesetaxel for Previously Treated Patients With Bladder Cancer

Phase 2 Unknown

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell